A patient who has Parkinson disease is being treated with the anticholinergic medication benztropine (Cogentin). The nurse will tell the patient that this drug will have which effect?
Reducing some of the tremors
Improving mental function
Helping the patient to walk faster
Minimizing symptoms of bradykinesia
The Correct Answer is A
A) Reducing some of the tremors: Benztropine (Cogentin) is an anticholinergic medication commonly used in the treatment of Parkinson's disease to help manage symptoms. It works by blocking the effects of acetylcholine, which can help to restore the balance between acetylcholine and dopamine in the brain. This helps reduce symptoms like tremors and rigidity, which are common in Parkinson’s disease. Although it may not completely eliminate these symptoms, it can significantly reduce tremors, making this the most accurate effect of the drug.
B) Improving mental function: Benztropine is not intended to improve mental function. In fact, anticholinergic medications like benztropine can sometimes cause cognitive side effects, including memory problems or confusion, particularly in older patients. While the drug is effective in reducing motor symptoms, it is not used to enhance cognitive abilities in Parkinson’s disease.
C) Helping the patient to walk faster: Benztropine does not directly improve gait speed or help a patient walk faster. The drug primarily targets motor symptoms like tremors and rigidity rather than improving bradykinesia (slowness of movement), which is often the cause of walking difficulty in Parkinson’s patients. Medications such as levodopa or dopamine agonists are typically used to address issues related to bradykinesia and movement speed.
D) Minimizing symptoms of bradykinesia: While benztropine can help manage tremors and rigidity, it is not particularly effective for bradykinesia, which is the hallmark symptom of Parkinson’s disease. Bradykinesia is best addressed with dopaminergic medications like levodopa or dopamine agonists. Therefore, benztropine would not be the first choice for minimizing bradykinesia symptoms.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A) Tacrine (Cognex): Tacrine is an acetylcholinesterase inhibitor used in the treatment of Alzheimer's disease to improve cognitive function. It is not typically used for Parkinson's disease, which is characterized by motor symptoms such as tremors, shuffling gait, and rigidity.
B) Rivastigmine (Exelon): Rivastigmine is another acetylcholinesterase inhibitor, similar to Tacrine, primarily used to treat Alzheimer's disease or dementia-related symptoms. While it helps with cognitive symptoms, it is not effective in treating the motor symptoms of Parkinson's disease.
C) Carbidopa-levodopa (Sinemet): This is the correct answer. Carbidopa-levodopa (Sinemet) is the gold standard treatment for Parkinson's disease. Levodopa is a precursor to dopamine, which helps address the dopamine deficiency in the brain that causes symptoms like tremors, shuffling gait, and lack of facial expression (masked facies). Carbidopa is added to prevent levodopa from being broken down before it reaches the brain, enhancing its effectiveness.
D) Donepezil (Aricept): Donepezil is also an acetylcholinesterase inhibitor used primarily in Alzheimer's disease. Like Tacrine and Rivastigmine, it works to improve cognitive function but does not treat the motor symptoms seen in Parkinson's disease. It would not be appropriate for managing the patient's Parkinsonian symptoms.
Correct Answer is A
Explanation
A) Celecoxib (Celebrex):
Celecoxib is a selective COX-2 inhibitor that targets the cyclooxygenase-2 enzyme, which is primarily responsible for inflammation, pain, and fever. COX-2 inhibitors tend to cause less gastrointestinal irritation compared to nonselective NSAIDs like aspirin, which block both COX-1 and COX-2 enzymes. Because aspirin is causing gastrointestinal upset, switching to Celecoxib, which is less likely to irritate the stomach lining, may be an appropriate option to prevent myocardial infarction while minimizing gastrointestinal discomfort.
B) Enteric-coated aspirin:
Enteric-coated aspirin is designed to dissolve in the small intestine rather than the stomach, which may reduce some gastrointestinal irritation. However, it does not eliminate the risk entirely, and it still functions as a COX-1 inhibitor. If the patient is already experiencing gastrointestinal upset, simply switching to enteric-coated aspirin may not be sufficient to alleviate the discomfort, and other options should be considered.
C) Nabumetone (Relafen):
Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) with some COX-2 selectivity. While it may cause less gastrointestinal upset than non-selective NSAIDs like aspirin, it is still an NSAID and carries a risk of gastrointestinal side effects, especially with prolonged use.
D) A COX-2 inhibitor:
While COX-2 inhibitors, including Celecoxib, are typically effective in reducing inflammation and pain with fewer gastrointestinal side effects than traditional NSAIDs, the term "a COX-2 inhibitor" could refer to various drugs, and Celecoxib (Celebrex) is the most commonly used.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.